Mitsubishi Tanabe Cuts Ties with Four-year Generics Subsidiary, But Sales Goals Remain
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe sold all shares of its Choseido Pharmaceutical subsidiary after not meeting expectations, and must now reassess its generics strategy.